Population heterogeneity in Plasmodium vivax relapse risk
Published version of a preprint
The DOI matches its Crossref record.
Abstract
A key characteristic of Plasmodium vivax parasites is their ability to adopt a latent liver-stage form called hypnozoites, able to cause relapse of infection months or years after a primary infection. Relapses of infection through hypnozoite activation are a major contributor to blood-stage infections in P vivax endemic regions and are thought to be influenced by factors such as febrile infections which may cause temporary changes in hypnozoite activation leading to ‘temporal heterogeneity’ in reactivation risk. In addition, immunity and variation in exposure to infection may be longer-term characteristics of individuals that lead to ‘population heterogeneity’ in hypnozoite activation. We analyze data on risk of P vivax in two previously published data sets from Papua New Guinea and the Thailand-Myanmar border region. Modeling different mechanisms of reactivation risk, we find strong evidence for population heterogeneity, with 30% of patients having almost 70% of all P vivax infections. Model fitting and data analysis indicates that individual variation in relapse risk is a primary source of heterogeneity of P vivax risk of recurrences. Trial Registration: ClinicalTrials.gov NCT01640574 , NCT01074905 , NCT02143934 .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is consistent with a growing body of evidence that relapse may be the primary cause of recurrence even in a number of settings with varying levels of transmission intensity [33][34][35].”
From Plasmodium vivax relapse reservoirs in Ethiopia: microhaplotype sequencing informs recurrent infection origins (2026) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 42
- World Health Organization, 2021, World Malaria Report 2021, 10.30875/6c551ba0-en · DOI · Paper page
- RN Price, 2020, Plasmodium vivax in the Era of the Shrinking P. falciparum Map., Trends in Parasitol, 36, 560, 10.1016/j.pt.2020.03.009 · DOI · Paper page
- A Voorberg-van der Wel, 2020, A dual fluorescent Plasmodium cynomolgi reporter line reveals in vitro malaria hypnozoite reactivation., Commun Biol., 3, 7, 10.1038/s42003-019-0737-3 · doi:10.1038/s42003-019-0737-3
- LJ Robinson, 2015, Strategies for Understanding and Reducing the Plasmodium vivax and Plasmodium ovale Hypnozoite Reservoir in Papua New Guinean Children: A Randomised Placebo-Controlled Trial and Mathematical Model., PLoS Med., 12, e1001891, 10.1371/journal.pmed.1001891 · DOI · Paper page
- I Mueller, 2009, Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite, Lancet Infect Dis, 9, 555, 10.1016/S1473-3099(09)70177-X · DOI · Paper page
- NJ White, 2011, Determinants of relapse periodicity in Plasmodium vivax malaria, Malaria Journal, 10, 297, 10.1186/1475-2875-10-297 · DOI · Paper page
- AI Adekunle, 2015, Modeling the Dynamics of Plasmodium vivax Infection and Hypnozoite Reactivation In Vivo, PLoS Negl Trop Dis, 9, e0003595, 10.1371/journal.pntd.0003595 · DOI · Paper page
- AR Taylor, 2019, Resolving the cause of recurrent Plasmodium vivax malaria probabilistically, Nature Communications, 10, 5595, 10.1038/s41467-019-13412-x · DOI · Paper page
- RJ Commons, 2020, Estimating the Proportion of Plasmodium vivax Recurrences Caused by Relapse: A Systematic Review and Meta-Analysis, Am J Trop Med Hyg
- GD Shanks, 2013, The activation of vivax malaria hypnozoites by infectious diseases, Lancet Infect Dis, 13, 900, 10.1016/S1473-3099(13)70095-1 · doi:10.1016/s1473-3099(13)70095-1
- MS Hossain, 2020, The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network., PLoS Med., 17, e1003393, 10.1371/journal.pmed.1003393 · DOI
- T Adak, 1998, Studies on the Plasmodium vivax Relapse Pattern in Delhi, India, Am J Trop Med Hyg, 59, 175, 10.4269/ajtmh.1998.59.175 · doi:10.4269/ajtmh.1998.59.175
- T Bousema, 2011, Adjusting for Heterogeneity of Malaria Transmission in Longitudinal Studies, J Infect Dis, 204, 1, 10.1093/infdis/jir225 · DOI · Paper page
- RM Corder, 2020, Modelling the epidemiology of residual Plasmodium vivax malaria in a heterogeneous host population: A case study in the Amazon Basin., PLoS Comput Biol, 16, e1007377, 10.1371/journal.pcbi.1007377 · DOI
- MT White, 2014, Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission., eLife, 3, e04692, 10.7554/eLife.04692 · DOI · Paper page
- S Mehra, 2020, An Activation-Clearance Model for Plasmodium vivax Malaria, Bulletin of Mathematical Biology, 82, 32, 10.1007/s11538-020-00706-1 · DOI
- Q Bassat, 2016, Key Knowledge Gaps for Plasmodium vivax Control and Elimination, Am J Trop Med Hyg, 95, 62, 10.4269/ajtmh.16-0180 · DOI
- G Stresman, 2019, Malaria Hotspots: Is There Epidemiological Evidence for Fine-Scale Spatial Targeting of Interventions?, Trends Parasitol, 35, 822, 10.1016/j.pt.2019.07.013 · DOI · Paper page
- C Louicharoen, 2009, Positively Selected G6PD-Mahidol Mutation Reduces Plasmodium vivax Density in Southeast Asians, Science, 326, 1546, 10.1126/science.1178849 · DOI · Paper page
- J Popovici, 2018, Genomic Analyses Reveal the Common Occurrence and Complexity of Plasmodium vivax Relapses in Cambodia., mBio, 9, e01888, 10.1128/mBio.01888-17 · DOI
- LH Schmidt, 1986, Compatibility of relapse patterns of Plasmodium cynomolgi infections in Resus monkeys with continuous cyclical development and hypnozoite concepts of relapse, Am J Trop Med Hyg, 35, 1077, 10.4269/ajtmh.1986.35.1077 · doi:10.4269/ajtmh.1986.35.1077
- N Chen, 2007, Relapses of Plasmodium vivax Infection Result from Clonal Hypnozoites Activated at Predetermined Intervals, The Journal of Infectious Diseases, 195, 934, 10.1086/512242 · DOI · Paper page
- CS Chu, 2019, Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria, Clinical Infectious Diseases, 68, 1311, 10.1093/cid/ciy735 · DOI
- L Cooper, 2019, Pareto rules for malaria super-spreaders and super-spreading, Nature Communications, 10, 3939, 10.1038/s41467-019-11861-y · DOI
- J Tarning, 2014, Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand., CPT Pharmacometrics Syst Pharmacol., 3, e132, 10.1038/psp.2014.29 · DOI
- RM Corder, 2020, Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil., PLoS Negl Trop Dis, 14, e0008526, 10.1371/journal.pntd.0008526 · DOI
- CS Chu, 2018, Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria, Clinical Infectious Diseases, 67, 1543, 10.1093/cid/ciy319 · DOI · Paper page
- NE Hofmann, 2017, The complex relationship of exposure to new Plasmodium infections and incidence of clinical malaria in Papua New Guinea., Elife, 6, 10.7554/eLife.23708 · DOI
- R Core Team, 2019, R: A language and environment for statistical computing.
- T. Therneau, 2015, A Package for Survival Analysis in S. Version 2.38
- Springer, 2000, Modeling Survival Data: Extending the Cox Model
- A Kassambara, 2019, survminer: Drawing Survival Curves using ‘ggplot2’. R package version 0.4.5
- JD Challenger, 2021, Predicting the public health impact of a malaria transmission-blocking vaccine, Nat Commun, 12, 1494, 10.1038/s41467-021-21775-3 · DOI
- JC Beier, 1992, Sporozoite Transmission by Anopheles Freeborni and Anopheles Gambiae Experimentally Infected with Plasmodium falciparum, Journal of the American Mosquito Control Association, 8, 404
- P Bejon, 2009, Analysis of Immunity to Febrile Malaria in Children That Distinguishes Immunity from Lack of Exposure, Infect Immun, 77, 1917, 10.1128/IAI.01358-08 · DOI · Paper page
- MT White, 2016, Variation in relapse frequency and the transmission potential of Plasmodium vivax malaria, Proc R Soc B, 283, 20160048, 10.1098/rspb.2016.0048 · DOI
- KE Battle, 2014, Geographical variation in Plasmodium vivax relapse, Malaria Journal, 13, 144, 10.1186/1475-2875-13-144 · DOI · Paper page
- L Molineaux, 2002, Malaria therapy reinoculation data suggest individual variation of an innate immune response and independent acquisition of antiparasitic and antitoxic immunities, Transactions of the Royal Society of Tropical Medicine and Hygiene, 96, 205, 10.1016/S0035-9203(02)90308-1 · DOI
- R Noviyanti, 2022, Hypnozoite depletion in successive Plasmodium vivax relapses., PLoS Negl Trop Dis, 16, e0010648, 10.1371/journal.pntd.0010648 · DOI
- CM Moreira, 2015, A systematic review of sub-microscopic Plasmodium vivax infection., Malar J., 14, 360, 10.1186/s12936-015-0884-z · DOI
- C Koepfli, 2013, A high force of plasmodium vivax blood-stage infection drives the rapid acquisition of immunity in papua new guinean children, PLoS Negl Trop Dis, 7, e2403, 10.1371/journal.pntd.0002403 · DOI
- P Michon, 2007, The Risk of Malarial Infections and Disease in Papua New Guinean Children, Am J Trop Med Hyg, 76, 997, 10.4269/ajtmh.2007.76.997 · DOI · Paper page
Cited by
Osborne, A. A., Ruybal-Pesantez, S., Rai, A., Trimarsanto, H., Hoon, K. S., Piera, K., Kleinecke, M., Rumaseb, A., Sutanto, E., Thriemer, K., et al. (2026) · doi:10.64898/2026.11.12.765293
Metadata
- Authors
- Stadler, E., Cromer, D., Mehra, S., Adekunle, A. I., Flegg, J. A., Anstey, N. M., Watson, J. A., Chu, C. S., Mueller, I., Robinson, L. J., Schlub, T. E., Davenport, M. P., & Khoury, D. S.
- ORCID
- Khoury, David S.
- Venue
- PLOS Neglected Tropical Diseases
- Publisher
- Public Library of Science (PLoS)
- Published
- 2022-12-19
- Volume
- 16
- Issue
- 12
- Pages
- e0010990
- ISSN
- 1935-2735
- Cited by
- 20
- References
- 0
- Language
- en
- Update notices
- new_version (2023-01-03)
- Funders
- Australian Research Council (DP120100064, DP180103875, DP200100747)
- National Health and Medical Research Council (1082022, 1173528, 1141921, 1080001, 1173027, 1135820, GNT1161627)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Population heterogeneity in Plasmodium vivax relapse risk. https://app.cochat.ai/papers/10.1371/journal.pntd.0010990
- The paper
- Stadler, E., Cromer, D., Mehra, S., Adekunle, A. I., Flegg, J. A., Anstey, N. M., Watson, J. A., Chu, C. S., Mueller, I., Robinson, L. J., Schlub, T. E., Davenport, M. P., & Khoury, D. S. (2022). Population heterogeneity in Plasmodium vivax relapse risk. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0010990
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.